lobbying_activities: 1590743

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1590743	a80a223d-d087-44f6-bb70-eaec1fd4d3a3	Q3	CROSSROADS STRATEGIES, LLC	400531586	LUMARA HEALTH	2014	third_quarter	PHA	Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2014-10-16T19:02:50.517000-04:00